摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-bromo-4-chloro-5-cyanopyrrolo[2,3-d]pyrimidin-4-one | 24391-39-7

中文名称
——
中文别名
——
英文名称
6-bromo-4-chloro-5-cyanopyrrolo[2,3-d]pyrimidin-4-one
英文别名
6-bromo-4-chloro-5-cyanopyrrolo[2,3-d]pyrimidine;6-bromo-4-chloro-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile;4-Chlor-5-cyan-6-brom-7H-pyrrolo<2,3-d>pyrimidin;6-bromo-4-chloro-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile
6-bromo-4-chloro-5-cyanopyrrolo[2,3-d]pyrimidin-4-one化学式
CAS
24391-39-7
化学式
C7H2BrClN4
mdl
——
分子量
257.477
InChiKey
PGBSSCFZSAVYJO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    13
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    65.4
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    6-bromo-4-chloro-5-cyanopyrrolo[2,3-d]pyrimidin-4-one 在 palladium on activated charcoal N,O-双三甲硅基乙酰胺sodium methylate 、 ammonium formate 作用下, 以 甲醇乙醇氯仿乙腈 为溶剂, 反应 22.75h, 生成 曲西瑞宾
    参考文献:
    名称:
    Triciribine 的改进全合成:具有抗肿瘤和抗病毒特性的三环核苷
    摘要:
    我们描述了从 4-氨基-6-溴-5-氰基吡咯并[2,3-d]嘧啶开始,高效全合成曲西瑞宾,一种具有抗肿瘤和抗病毒特性的三环核苷。†为了纪念和庆祝 Leroy B. Townsend 教授 70 岁生日。
    DOI:
    10.1081/ncn-120027815
  • 作为产物:
    描述:
    6-bromo-5-cyanopyrrolo[2,3-d]pyrimidin-4-one三乙胺三氯氧磷 作用下, 以 乙腈 为溶剂, 以38.43%的产率得到6-bromo-4-chloro-5-cyanopyrrolo[2,3-d]pyrimidin-4-one
    参考文献:
    名称:
    通过建模,底物和酶工程靶向大肠杆菌腈还原酶QueF的底物结合位点
    摘要:
    腈还原酶QueF催化将2-氨基-5-氰基吡咯并[2,3- d ]嘧啶-4-酮(preQ 0)还原为2-氨基-5-氨基甲基吡咯并[2,3 - d ]嘧啶-4-酮(preQ 1)在超修饰核苷quesusine的生物合成途径中。它是已知的唯一一种将腈还原为相应的伯胺的酶,因此可以扩大腈的生物催化反应工具箱。为了评估这种新的氧化还原酶在生物催化反应中的应用,研究其底物范围是必要的。我们在这里报告对大肠杆菌的腈还原酶QueF的活性位点结合特性和底物范围的研究。具有简单腈结构的筛选显示了高底物特异性。因此,根据大肠杆菌QueF的新同源性模型以及天然和非天然底物的复杂结构模型,确定了底物与活性位点的结合相互作用。合成了天然底物preQ 0的各种结构类似物,并用来自大肠杆菌的野生型QueF和几个活性位点突变体进行了筛选。已显示两个氨基酸残基Cys190和Asp197在催化机理中起重要作用。通过使用野生型和
    DOI:
    10.1002/chem.201300163
点击查看最新优质反应信息

文献信息

  • An Expedient Total Synthesis of Triciribine
    作者:Chen Hu、Zhizhong Ruan、Haixin Ding、Yirong Zhou、Qiang Xiao
    DOI:10.3390/molecules22040643
    日期:——
    In the present paper, we report an expedient total synthesis of triciribine, a tricyclic 7-deazapurine nucleoside and protein kinase B (AKT ) inhibitor, in 35% overall yield. Our synthesis route features a highly regioselective substitution of 1-N-Boc-2-methylhydrazine and a trifluoroacetic acid catalyzed one-pot transformation which combined the deprotection of the tert-butylcarbonyl (Boc) group and
    在本论文中,我们报告了三环 7-脱氮嘌呤核苷和蛋白激酶 B (AKT) 抑制剂曲西瑞滨的权宜全合成,总产率为 35%。我们的合成路线以 1-N-Boc-2-甲基肼的高度区域选择性取代和三氟乙酸催化的一锅转化为特色,将叔丁基羰基 (Boc) 基团的脱保护和闭环反应结合在一起得到三环核碱基主题。
  • Deoxy Sugar Analogues of Triciribine:  Correlation of Antiviral and Antiproliferative Activity with Intracellular Phosphorylation
    作者:Anthony R. Porcari、Roger G. Ptak、Katherine Z. Borysko、Julie M. Breitenbach、Sauro Vittori、Linda L. Wotring、John C. Drach、Leroy B. Townsend
    DOI:10.1021/jm990205m
    日期:2000.6.1
    Triciribine (TCN) and triciribine monophosphate (TCN-P) have antiviral and antineoplastic activity at low micromolar or submicromolar concentrations. In an effort to improve and better understand this activity, we have conducted a structure-activity relationship study to explore requirements for the number of hydroxyl groups on the ribosyl moiety for biological activity. 2'-Deoxytriciribine (2'-dTCN), 3'-deoxytriciribine (3'-dTCN), 2',3'-epoxytriciribine (2',3'-epoxyTCN), 2',3'-dideoxy-2',3'-didehydrotriciribine (2',3'-d4TCN), and 2',3'-dideoxytriciribine (2',3'-ddTCN) were synthesized and evaluated for activity against human immunodeficiency virus (HIV-1), herpes simplex virus type 1 (HSV-1), and human cytomegalovirus (HCMV). Antiproliferative activity of the compounds also was tested in murine L1210 cells and three human tumor cell lines. All compounds were either less active than TCN and TCN-P or inactive at the highest concentration tested (100 mu M) in both antiviral and antiproliferative assays. Reverse-phase HPLC of extracts from uninfected cells treated with the deoxytriciribine analogues only detected the conversion of 3'-dTCN and 2',3'-ddTCN to their respective monophosphates. Therefore, either the deoxytriciribine analogues were not transported across the cell membrane or, more likely, they were not substrates for a nucleoside kinase or phosphotransferase. We have concluded that the hydroxyl groups on the ribosyl ring system of TCN and TCN-P must be intact in order to obtain significant antiviral and antineoplastic activity.
  • GUPTA, PRANAB K.;VITTORI, SAURO;TOWNSEND, LEROY B., NUCLEOSIDES AND NUCLEOTIDES , 9,(1990) N, C. 35-41
    作者:GUPTA, PRANAB K.、VITTORI, SAURO、TOWNSEND, LEROY B.
    DOI:——
    日期:——
  • [EN] DEAZAPURINE NUCLEOSIDE LIBRARIES AND COMPOUNDS<br/>[FR] BANQUES DE DEAZAPURINE NUCLEOSIDES ET COMPOSES
    申请人:RIBAPHARM INC
    公开号:WO2003051899A1
    公开(公告)日:2003-06-26
    Deazapurine nucleoside analog libraries are prepared in a combinatorial library approach. Particularly preferred compounds and libraries include various 7-deazapurines, 9-deazapurines, and 7-deaza-8-azaguanosine as heterocyclic bases, and it is generally preferred that such nucleosides include a ribofuranose as the sugar moiety. It is further contemplated that compounds generated using contemplated libraries may be useful in the treatment of various conditions, particularly viral infections and neoplastic diseases.
  • Targeting the Substrate Binding Site of<i>E. coli</i>Nitrile Reductase QueF by Modeling, Substrate and Enzyme Engineering
    作者:Birgit Wilding、Margit Winkler、Barbara Petschacher、Regina Kratzer、Sigrid Egger、Georg Steinkellner、Andrzej Lyskowski、Bernd Nidetzky、Karl Gruber、Norbert Klempier
    DOI:10.1002/chem.201300163
    日期:2013.5.27
    biocatalytic reactions, investigation of its substrate scope is prerequisite. We report here an investigation of the active site binding properties and the substrate scope of nitrile reductase QueF from Escherichia coli. Screenings with simple nitrile structures revealed high substrate specificity. Consequently, binding interactions of the substrate to the active site were identified based on a new homology
    腈还原酶QueF催化将2-氨基-5-氰基吡咯并[2,3- d ]嘧啶-4-酮(preQ 0)还原为2-氨基-5-氨基甲基吡咯并[2,3 - d ]嘧啶-4-酮(preQ 1)在超修饰核苷quesusine的生物合成途径中。它是已知的唯一一种将腈还原为相应的伯胺的酶,因此可以扩大腈的生物催化反应工具箱。为了评估这种新的氧化还原酶在生物催化反应中的应用,研究其底物范围是必要的。我们在这里报告对大肠杆菌的腈还原酶QueF的活性位点结合特性和底物范围的研究。具有简单腈结构的筛选显示了高底物特异性。因此,根据大肠杆菌QueF的新同源性模型以及天然和非天然底物的复杂结构模型,确定了底物与活性位点的结合相互作用。合成了天然底物preQ 0的各种结构类似物,并用来自大肠杆菌的野生型QueF和几个活性位点突变体进行了筛选。已显示两个氨基酸残基Cys190和Asp197在催化机理中起重要作用。通过使用野生型和
查看更多

同类化合物

(2R,3S,5R)-5-(4-氨基-7H-吡咯[2,3-D]嘧啶-7-基-2 -(羟甲基)四氢呋喃-3-醇 鲁索替尼 鲁索利尼杂质C 迪高替尼 诺那吡胺 螺[4.4]壬烷-1-酮,6-氨基-,(5S,6S)- 苯酚,2,4-二氯-5-肼-,单盐酸 苯并呋喃,2,3-二氢-3-(1-甲基乙基)- 聚(氧代-1,2-乙二基),a-甲基-w-[[3,4,4,4-四氟-2-[1,2,2,2-四氟-1-(三氟甲基)乙基]-1,3-二(三氟甲基)-1-丁烯-1-基]氧代]- 维贝格龙 磷酸鲁索替尼 甲基7-(2-甲氧基乙基)-1,3-二甲基-2,4-二羰基-2,3,4,7-四氢-1H-吡咯并[2,3-D]嘧啶-6-羧酸酯 托法替尼杂质28 托法替尼杂质2 托伐替尼杂质T 异丙基2-氨基-4-甲氧基-7h-吡咯并[2,3-d]嘧啶-6-羧酸 巴里替尼杂质5 巴瑞替尼 巴瑞克替尼杂质 巴瑞克替尼中间体3 巴瑞克替尼中间体1 外消旋鲁替替尼-d8 培美酸 吡啶,1-[(2,5-二甲基苯基)甲基]-1,2,3,6-四氢- 吡咯并[1,2-a]嘧啶-3-羧酸 吡咯并[1,2-F]嘧啶-3-甲酸乙酯 吡咯并[1,2-A]嘧啶-6-羧酸 吡咯并[1,2-A]嘧啶-6-甲醛 叔丁基2-氨基-4-氯-5H-吡咯并[3,4-D]嘧啶-6(7H)-羧酸酯 叔丁基-4-氯-2-吗啉代-7H-吡咯并[2,3-D]嘧啶-7-甲酸甲酯 十二烷-1,12-二基二(苯甲基二甲基铵)二氯化 亚乙基,2-氨基-1-(乙酯基<乙氧羰基>)-2-(甲酰基亚氨基)-,(2Z)-(9CI) 二环[2.2.1]庚-5-烯-2-羧酸,丁基酯,(1R,2R,4R)- [4-(1H-吡唑-4-基)-7H-吡咯并[2,3-D]嘧啶-7-基]甲基特戊酸酯 [3-(4-氨基-7H-吡咯并[2,3-d]嘧啶-7-基)环戊基]甲醇 [1-(乙基磺酰基)-3-[4-(7H-吡咯并[2,3-d]嘧啶-4-基)-1H-吡唑-1-基]氮杂环丁烷-3-基]乙腈磷酸盐 S-鲁索替尼 PF-04965842(阿布罗替尼) N-苯基-5H-吡咯并(3,2-d)嘧啶-4-胺 N-苄基-7H-吡咯并[2,3-d]嘧啶-4-胺 N-苄基-5H-吡咯并[3,2-d]嘧啶-4-胺 N-甲基-N-((3S,4S)-4-甲基哌啶-3-基)-7H-吡咯并[2,3-D]嘧啶-4-胺 N-甲基-N-((3R,4R)-4-甲基哌啶-3-基)-7H-吡咯并[2,3-D]嘧啶-4-胺 N-甲基-7h-吡咯并[2,3-d]嘧啶-4-胺 N-甲基-1-((1R,4R)-4-(甲基(7H吡咯[2,3-D]嘧啶-4-基)氨基)环己基)甲磺酰胺富马酸甲酯 N-(5-溴-4-氯-7H-吡咯并[2,3-d]嘧啶-2-基)-2,2-二甲基-丙酰胺 N-(4-甲氧基苯基)-5H-吡咯并(3,2-d)嘧啶-4-胺 N-(4-氯-7H-吡咯并[2,3-D]嘧啶-2-基)-2,2-二甲基丙酰胺 N-(4-氯-5-碘-7H-吡咯[2,3-D]嘧啶-2-基)-2,2-二甲基丙酰胺 N-(4-氯-5-氰基-7H-吡咯并[2,3-d]嘧啶-2-基)-2,2-二甲基丙酰胺